Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Two major clinical trials support safety and efficacy of TOBI in cystic fibrosis patients

Jan. 11, 1999

Magainin and Genentech enter collaboration for asthma treatment

Jan. 11, 1999

New LTB4 receptor antagonists disclosed by Boehringer Ingelheim

Dec. 30, 1998

Anti-IL-5R monoclonal antibodies and antagonists in development by Tanox

Dec. 29, 1998

Improvement in ischemia-reperfusion lung injury by treatment with FR-167653

Dec. 28, 1998

Japanese approval sought for Accolate

Dec. 23, 1998

PathoGenesis reports encouraging phase II results for TOBI in bronchiectasis

Dec. 23, 1998

Pharmacological profile of dual LTD4/TxA2 receptor antagonist YM-158

Dec. 21, 1998

HMR patents new series of tachykinin receptor antagonists for asthma, cough and bronchitis

Dec. 18, 1998

Leukotriene biosynthesis inhibitors described by Ortho-McNeil for inflammatory disorders

Dec. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.